Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06194695
Status:
RECRUITING
Last Update Posted:
2024-01-09
First Post:
2023-12-22
Brief Title:
DEB-TACE Lenvatinib and Anti-PDL1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma
Sponsor:
Ze-yang Ding MD
Organization:
Tongji Hospital